Prasugrel Tablet, Film Coated
Product Images NDC 65162-001

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Prasugrel (NDC 65162-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Prasugrel Tablets 1)

A line chart comparing the cumulative incidence of non-CABG-related TIMI major or minor bleeding events (%) over days from randomization for Prasugrel and Clopidogrel. The chart includes a number at risk table below for each time point, and an inset zooms in on early days showing the trend between the two drugs.*

FDA Label Image

Figure 2 (Prasugrel Tablets 2)

Chemical structure of Prasugrel hydrochloride showing the molecular arrangement of its active ingredient.*

FDA Label Image

10 (Prasugrel Tablets 3)

A line graph depicting the percentage inhibition of platelet aggregation over time (hours) with mean and standard deviation, using 20 µM ADP as the inducer. The x-axis represents time in hours, and the y-axis represents the inhibition percentage, showing rapid increase and plateauing between 70-80% inhibition after approximately 2 hours.*

FDA Label Image

10 (Prasugrel Tablets 4)

A line graph comparing cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke over days from randomization between Prasugrel and Clopidogrel in UA/NSTEMI patients. The graph shows cumulative incidence (%) with statistical significance values indicated for comparison.*

FDA Label Image

10 (Prasugrel Tablets 5)

A Kaplan-Meier survival curve comparing cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke incidence over 450 days between Prasugrel and Clopidogrel treatment for STEMI patients. The chart shows lower event rates with Prasugrel versus Clopidogrel, with a p-value of 0.02 indicating statistical significance. An inset graph displays the first 7 days with a p-value of 0.008.*

FDA Label Image

10 (Prasugrel Tablets 6)

A forest plot chart depicting baseline characteristics and related hazard ratios comparing percent events between Prasugrel and Clopidogrel. The chart displays subgroups by age, gender, body weight, region, diabetes status, metabolic syndrome, previous medical events, time from symptom onset, stent type, and inhibitor use, with corresponding numerical data and confidence intervals visually represented to compare drug performance.*

FDA Label Image

10 (Prasugrel Tablets 7)

A forest plot chart comparing baseline characteristics and percent event rates between Prasugrel and Clopidogrel treatment groups in a clinical study. Characteristics such as age, gender, body weight, region, diabetes, metabolic syndrome, previous medical conditions, and treatment details are listed with corresponding hazard ratios and confidence intervals displayed to show which drug performed better.*

FDA Label Image

Vb (Prasugrel Tablets 8)

Label for Prasugrel Tablets 5 mg film-coated oral tablets by Amneal Pharmaceuticals LLC. The label indicates the quantity as 30 tablets and includes storage instructions, dosage form, and manufacturer details. The label also features warnings about dispensing and sealing integrity.*

FDA Label Image

Ad (Prasugrel Tablets 9)

Prasugrel Tablets 10 mg film-coated oral tablets packaging label by Amneal Pharmaceuticals LLC. The label includes dosage instructions, storage conditions, manufacturer and distributor information, and a barcode. Package contains 30 tablets. The label specifies prescription use only and instructions to keep in the original container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.